3 hours Genmab A/S (NASDAQ:GMAB) Receives “Buy” Rating from HC WainwrightMarketBeat
HC Wainwright reissued a “buy” rating and issued a $50.00 price target on shares of Genmab A/S in a report on Wednesday.
XHC Wainwright reissued a “buy” rating and issued a $50.00 price target on shares of Genmab A/S in a report on Wednesday.
X